Fennec Pharmaceuticals, Inc. (FENC)
12.76
+1.14
(+9.81%)
USD |
NASDAQ |
Nov 16, 16:00
12.58
-0.18
(-1.41%)
After-Hours: 20:00
Fennec Pharmaceuticals Price to Book Value : 9.135 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 9.135 |
| November 13, 2026 | 8.319 |
| November 12, 2026 | 7.803 |
| November 11, 2026 | 7.617 |
| November 10, 2026 | 7.574 |
| November 09, 2026 | 7.753 |
| November 06, 2026 | 7.023 |
| November 05, 2026 | 6.722 |
| November 04, 2026 | 7.410 |
| November 03, 2026 | 7.660 |
| November 02, 2026 | 7.546 |
| October 30, 2026 | 7.331 |
| October 29, 2026 | 7.839 |
| October 28, 2026 | 7.782 |
| October 27, 2026 | 7.603 |
| October 26, 2026 | 7.266 |
| October 23, 2026 | 7.216 |
| October 22, 2026 | 7.388 |
| October 21, 2026 | 7.431 |
| October 20, 2026 | 7.488 |
| October 19, 2026 | 7.352 |
| October 16, 2026 | 7.145 |
| October 15, 2026 | 7.410 |
| October 14, 2026 | 7.145 |
| October 13, 2026 | 7.288 |
| Date | Value |
|---|---|
| October 12, 2026 | 7.674 |
| October 09, 2026 | 7.667 |
| October 08, 2026 | 7.61 |
| October 07, 2026 | 7.417 |
| October 06, 2026 | 7.410 |
| October 05, 2026 | 7.603 |
| October 02, 2026 | 7.302 |
| October 01, 2026 | 7.395 |
| September 30, 2026 | 7.624 |
| September 29, 2026 | 8.915 |
| September 28, 2026 | 9.039 |
| September 25, 2026 | 8.754 |
| September 24, 2026 | 8.766 |
| September 23, 2026 | 8.676 |
| September 22, 2026 | 9.088 |
| September 21, 2026 | 9.006 |
| September 18, 2026 | 8.766 |
| September 17, 2026 | 8.898 |
| September 16, 2026 | 8.709 |
| September 15, 2026 | 8.783 |
| September 14, 2026 | 8.849 |
| September 11, 2026 | 9.047 |
| September 10, 2026 | 9.328 |
| September 09, 2026 | 9.617 |
| September 08, 2026 | 10.28 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.325 |
| Alnylam Pharmaceuticals, Inc. | 5.934 |
| Anika Therapeutics, Inc. | 1.258 |
| Savara, Inc. | 8.509 |
| Arrowhead Pharmaceuticals, Inc. | 124.15 |
Price to Book Value Related Metrics
| PE Ratio | 764.07 |
| PS Ratio | 6.788 |
| Price to Free Cash Flow | 383.13 |
| Price | 12.76 |
| Earnings Yield | 0.13% |
| Market Cap | 449.34M |
| Operating PE Ratio | 138.37 |
| Normalized PE Ratio | 205.48 |